{"brief_title": "Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.", "brief_summary": "Assessment of safety and efficacy of SU11248 in patients with metastatic colorectal cancer who have failed selected previous treatments.", "condition": "Colorectal Neoplasms", "intervention_type": "Drug", "intervention_name": "SU011248", "criteria": "Inclusion Criteria: - Metastatic colorectal cancer - Failed selected cancer therapies in the past. Exclusion Criteria: - Prior treatment with tyrosine kinase inhibitors or VEGF inhibitors other than bevacizumab.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00077987.xml"}